(-)-OSU 6162 inhibits levodopa-induced dyskinesias in a monkey model of Parkinson's disease

NeuroReport

Volumn 8, Issue 11, 1997, Pages 2567-2570

  Ekesbo, Anna ^a   Andrén, Per E ^b   Gunne, Lars M ^b   Tedroff, Joakim ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

( ) OSU 6162; Dyskinesias; Levodopa; MPTP; Parkinson's discase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 [3 (METHYLSULFONYL)PHENYL] 1 PROPYLPIPERIDINE; CARBIDOPA; DOPAMINE 2 RECEPTOR BLOCKING AGENT; LEVODOPA; RACLOPRIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DYSKINESIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MARMOSET; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030876755     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199707280-00029     Document Type: Article

References (18)

1. Nutt JG. Neurology 40, 340-345 (1990).
2. Tanner C. Drug induced movement disorders (tardive dyskinesia and L-dopa induced dyskinesia). In: Vinken PJ, Bruyn GW and Klawans HL, eds. Extrapyramidal Disorders. Handbook of Clinical Neurology. Vol 5. Amsterdam: Elsevier, 1986: 185-204.
3. Boyce S, Rupniak NMJ, Steventon MJ and Iversen SD. Clin Neuropharmacol 13, 448-458 (1990).
4. Horstink MWIM, Zijlmans JCM, Pasman JW et al. J Neurol Neurosurg Psychiatry 53, 224-226 (1990).
5. Langston WJ and Ballard, P. Can J Neurol Sci 11, 160-165 (1984).
6. Schultz W. Gen Pharmacol 19, 153-161 (1988).
7. Jenner P, Rupniak NM, Rose S et al. Neurosci Lett 50, 85-90 (1984).
8. Bédard PJ, Di Paolo T, Falardeau P and Boucher R. Brain Res 379, 294 (1986).
9. Sonesson C. Doctorial Thesis. Arylpiperidine and arylpyrrolidine derivatives with potential antipsychotic efficacy. Synthesis and quantitative structure-activity relationships. Acta Universitatis Upsaliensis (1995).
10. Tedroff J, Sonesson C, Waters N and Carlsson A. Mov Disord 12, S112 (1997).
11. Neu H, Hartvig P, Torstenson R et al. Nucl Med Biol (in press) (1997).
12. Klawans HL and Weiner WJ. J Neural Neurosurg Psychiatry 37, 427-430 (1974).
13. Pearce RKB, Jackson M, Smith L et al. Mov Disord 10, 731-740 (1995).
14. Mouradian MM, Juncos JL, Fabbrini G et al. Ann Neurol 24, 372-378 (1988).
15. Blanchet PJ, Gomez-Mancilla B and Bedard PJ. J Neural Transm 45 (Suppl.), 103-112 (1995).
16. Tedroff J, Pedersen M, Aquilonius S-M et al. Neurology 46, 1430-1436 (1996).
17. Torstenson R, Hartvig P, Långström B et al. Ann Neurol 41, 334-340 (1997).
18. Ögren SO, Hall H, Köhler C et al. Psychopharmacology 90, 287-294 (1986).